14, 2024 — More than a quarter of Australians over the age of 50 take cholesterol-lowering drugs ... gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity ...
The Cholesterol and Recurrent Events (CARE) study, a secondary prevention trial, proved the benefit of treating patients with myocardial ischemia and cholesterol levels within normal limits.